Mercuric iodide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
|genericName=Mercuric iodide
|genericName=Mercuric iodide
|aOrAn=a
|aOrAn=a
|drugClass=antiseptic
|drugClass=[[antiseptic]]
|indicationType=treatment
|indicationType=treatment
|indication=Sore Throat
|indication=[[Sore Throat]]
|adverseReactions=fasciculations, paresthesias, irritability, insomnia
|adverseReactions=[[fasciculations]], [[paresthesias]], [[irritability]], [[insomnia]]




Line 23: Line 23:


====Directions====
====Directions====
Take at onset of symptoms.  Repeat every 2 hours or as needed until relieved.  If condition persists or worsens discontinue use and consult a practitioner.
* Take at onset of symptoms.  Repeat every 2 hours or as needed until relieved.  If condition persists or worsens discontinue use and consult a practitioner.


Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth.  Children and infants: 1-5 pellets.
* Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth.  Children and infants: 1-5 pellets.
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


Line 38: Line 38:


====Directions====
====Directions====
Take at onset of symptoms.  Repeat every 2 hours or as needed until relieved.  If condition persists or worsens discontinue use and consult a practitioner.
* Take at onset of symptoms.  Repeat every 2 hours or as needed until relieved.  If condition persists or worsens discontinue use and consult a practitioner.


Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth.  Children and infants: 1-5 pellets.
* Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth.  Children and infants: 1-5 pellets.
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


Line 57: Line 57:
<!--Clinical Trials Experience-->
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
=====Body as a Whole=====
=====Cardiovascular=====
=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====
=====Respiratory=====
=====Skin and Hypersensitivy Reactions=====
=====Special Senses=====
=====Urogenital=====
=====Miscellaneous=====






<!--Postmarketing Experience-->
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=[[fasciculations]], [[paresthesias]], [[irritability]], [[insomnia]]
 
=====Body as a Whole=====
 
 
 
=====Cardiovascular=====
 
 
 
=====Digestive=====
 
 
 
=====Endocrine=====
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
=====Metabolic and Nutritional=====
 
 
 
=====Musculoskeletal=====
 
 
 
=====Neurologic=====
 
 
 
=====Respiratory=====
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 




<!--Drug Interactions-->
<!--Drug Interactions-->
|drugInteractions=* Drug
|drugInteractions=
:* Description


<!--Use in Specific Populations-->
<!--Use in Specific Populations-->
Line 198: Line 84:


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
|administration=* Oral
|administration=* [[Oral]]
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.




Line 279: Line 164:


<!--Mechanism of Action-->
<!--Mechanism of Action-->
|mechAction=*
|mechAction=  


<!--Structure-->
<!--Structure-->
|structure=* ACTIVE INGREDIENT
|structure=* ACTIVE INGREDIENT
MERCURIUS IODATUS RUBER
:* MERCURIUS IODATUS RUBER
INACTIVE INGREDIENTS
* INACTIVE INGREDIENTS
Inactive Ingredients - Lactose, Sucrose  
:* Inactive Ingredients - Lactose, Sucrose  




Line 302: Line 187:


<!--How Supplied-->
<!--How Supplied-->
|howSupplied=*
|howSupplied=
|packLabel=PACKAGE LABEL
|packLabel=====PACKAGE LABEL====
: [[File:Mercury PDP.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
: [[File:Mercury PDP.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]


Line 322: Line 207:
|drugShortage=
|drugShortage=
}}
}}
{{PillImage
|fileName=No image.jpg
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
<!--Pill Image-->
<!--Label Display Image-->





Revision as of 19:37, 22 April 2015

Mercuric iodide
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Mercuric iodide is a antiseptic that is FDA approved for the treatment of Sore Throat. Common adverse reactions include fasciculations, paresthesias, irritability, insomnia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

  • To be used for acute self-limiting conditions according to standard homeopathic indications

Directions

  • Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If condition persists or worsens discontinue use and consult a practitioner.
  • Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth. Children and infants: 1-5 pellets.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mercuric iodide in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercuric iodide in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

  • To be used for acute self-limiting conditions according to standard homeopathic indications

Directions

  • Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If condition persists or worsens discontinue use and consult a practitioner.
  • Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth. Children and infants: 1-5 pellets.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mercuric iodide in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercuric iodide in pediatric patients.

Contraindications

  • None

Warnings

  • If pregnant or nursing, consult a practitioner before using.
  • Keep these and all medications out of the reach of children.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Mercuric iodide in the drug label.

Postmarketing Experience

fasciculations, paresthesias, irritability, insomnia

Drug Interactions

There is limited information regarding Mercuric iodide Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • If pregnant or nursing, consult a practitioner before using.


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Mercuric iodide in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Mercuric iodide during labor and delivery.

Nursing Mothers

  • If pregnant or nursing, consult a practitioner before using.

Pediatric Use

There is no FDA guidance on the use of Mercuric iodide with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Mercuric iodide with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Mercuric iodide with respect to specific gender populations.

Race

There is no FDA guidance on the use of Mercuric iodide with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Mercuric iodide in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Mercuric iodide in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Mercuric iodide in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Mercuric iodide in patients who are immunocompromised.

Administration and Monitoring

Administration

Monitoring

There is limited information regarding Monitoring of Mercuric iodide in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Mercuric iodide in the drug label.

Overdosage

There is limited information regarding Overdose of Mercuric iodide in the drug label.

Pharmacology

Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox E numberTemplate:Chembox AppearanceTemplate:Chembox OdourTemplate:Chembox DensityTemplate:Chembox MeltingPtTemplate:Chembox BoilingPtTemplate:Chembox SolubilityInWaterTemplate:Chembox SolubilityTemplate:Chembox RefractIndexTemplate:Chembox StructureTemplate:Chembox EUClassTemplate:Chembox RPhrasesTemplate:Chembox SPhrasesTemplate:Chembox NFPATemplate:Chembox FlashPtTemplate:Chembox OtherAnionsTemplate:Chembox OtherCationsTemplate:Chembox Supplement
Template:Chembox header2 | Mercury(II) iodide
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
DrugBank
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
UNII
Properties
HgI2
Molar mass 454.40 g/mol
Hazards
Related compounds
Template:Chembox header2 | Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Mechanism of Action

There is limited information regarding Mercuric iodide Mechanism of Action in the drug label.

Structure

  • ACTIVE INGREDIENT
  • MERCURIUS IODATUS RUBER
  • INACTIVE INGREDIENTS
  • Inactive Ingredients - Lactose, Sucrose

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Mercuric iodide in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Mercuric iodide in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Mercuric iodide in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Mercuric iodide in the drug label.

How Supplied

There is limited information regarding Mercuric iodide How Supplied in the drug label.

Storage

There is limited information regarding Mercuric iodide Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Mercuric iodide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

PACKAGE LABEL

This image is provided by the National Library of Medicine.

Ingredients and Appearance

This image is provided by the National Library of Medicine.

{{#ask: Label Page::Mercuric iodide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Mercuric iodide in the drug label.

Precautions with Alcohol

  • Alcohol-Mercuric iodide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • SORE THROAT LEFT SIDE®[1]

Look-Alike Drug Names

There is limited information regarding look alike drug names.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. "Mercuric iodide".